(36) found that tumor suppressor genes such as TSC2 negatively regulate signaling pathways controlling cell growth and proliferation; the pY1611S mutation located within the Rap/RanGAP domain of TSC2 may lead to functional loss, resulting in deregulated tumor cell proliferation following ICI treatment. Here, TSC2 is linked to neoplasm.